Merck
Merck is a global pharmaceutical leader known for its significant contributions to oncology and vaccine development. In recent years, the company has focused on personalized medicine and mRNA-based therapies, often collaborating with biotechnology firms to advance cancer treatment protocols.
Merck & Co., known as MSD outside the United States and Canada, is one of the world's largest pharmaceutical companies. With a history spanning over a century, the organization has evolved into a cornerstone of modern medical research, particularly in the fields of infectious diseases and oncology. The company's strategic focus in the mid-2020s has increasingly shifted toward precision medicine—treatments tailored to the genetic profile of individual patients.
In the context of Israeli and global health security, Merck's role is pivotal due to its extensive research infrastructure and its capacity to bring high-stakes clinical trials to fruition. The company has maintained a consistent presence in the Israeli medical ecosystem, collaborating with local research institutions and providing advanced therapeutic options to the Israeli healthcare system. Its oncology portfolio, led by blockbuster immunotherapy treatments, has set benchmarks for cancer care worldwide.
Recently, Merck has gained significant attention for its partnership with Moderna in the development of experimental cancer vaccines. This collaboration leverages mRNA technology—the same platform used for COVID-19 vaccines—to create personalized treatments for melanoma. By targeting the specific mutations of a patient's tumor, Merck aims to prevent cancer recurrence, a development that represents a major shift from traditional broad-spectrum chemotherapy toward targeted biological intervention. The success of these trials in 2026 underscores Merck's position at the forefront of the next generation of oncology, offering new hope for patients with high-risk cancers. As the pharmaceutical landscape continues to integrate biotechnology and genomic data, Merck remains a central actor in defining the future of global health and therapeutic innovation.